Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
American Journal of Therapeutics
|
December 4, 2025
A Case of an Elderly Bullous Pemphigoid Patient With Enterostomy Was Effectively Treated With Dupilumab
Sheng Li, Bing-Jun Shi
American Journal of Therapeutics
|
January 8, 2026
Effective Treatment of Darier Disease With Abrocitinib Combined and Acitretin Capsules: A Case Report
Xiang-Yu Chen, Bing-Jun Shi
American Journal of Therapeutics
|
November 29, 2025
Tofacitinib: A Potential Dual-Action Agent in Resolving Generalized Granuloma Annulare and Modulating HIV Reservoirs
Yao Lei, Xiao-Qin Wang, Bing-Jun Shi
American Journal of Therapeutics
|
April 9, 2026
Abrocitinib for Lichen Planus
Xiao-Yu Wu, Hua Liu, Bing-Jun Shi
Lasers in Medical Science
|
January 25, 2025
No differences in the number of pigment cells and pigment particles between Bier spots and normal skin were observed on Skin Confocal Microscopy
Xin-Yu Wei, Yin Yu, Bing-Jun Shi
American Journal of Therapeutics
|
April 4, 2025
Abrocitinib Successfully Treated Dupilumab-Resistant Patients With Rare Dominant Dystrophic Epidermolysis Bullosa With Atopic Dermatitis
Hai-Zhen Hui, Hong-Xing Guo, Bing-Jun Shi
American Journal of Therapeutics
|
June 15, 2026
Abrocitinib for Erythema Multiforme-like Drug Eruptions
Xiang-Yu Chen, Xin-Yu Wei, Bing-Jun Shi
American Journal of Therapeutics
|
November 4, 2025
JAK Inhibitors in the Treatment of Hailey-Hailey Disease: A Case Series and Mechanistic Exploration
Yu-Ting Gan, Yuan-Fang Wan, Bing-Jun Shi
American Journal of Therapeutics
|
February 27, 2026
Tofacitinib in Pigmented Purpuric Dermatoses
Yu-Ting Gan, Xing-Ying Liu, Hua Liu, et al.
American Journal of Therapeutics
|
March 2, 2026
Tislelizumab-Associated Toxic Epidermal Necrolysis
Zheng Guan, YuTing Gan, Qi Pan, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
American Journal of Therapeutics
|
December 4, 2025
A Case of an Elderly Bullous Pemphigoid Patient With Enterostomy Was Effectively Treated With Dupilumab
Sheng Li, Bing-Jun Shi
American Journal of Therapeutics
|
January 8, 2026
Effective Treatment of Darier Disease With Abrocitinib Combined and Acitretin Capsules: A Case Report
Xiang-Yu Chen, Bing-Jun Shi
American Journal of Therapeutics
|
November 29, 2025
Tofacitinib: A Potential Dual-Action Agent in Resolving Generalized Granuloma Annulare and Modulating HIV Reservoirs
Yao Lei, Xiao-Qin Wang, Bing-Jun Shi
American Journal of Therapeutics
|
April 9, 2026
Abrocitinib for Lichen Planus
Xiao-Yu Wu, Hua Liu, Bing-Jun Shi
Lasers in Medical Science
|
January 25, 2025
No differences in the number of pigment cells and pigment particles between Bier spots and normal skin were observed on Skin Confocal Microscopy
Xin-Yu Wei, Yin Yu, Bing-Jun Shi
American Journal of Therapeutics
|
April 4, 2025
Abrocitinib Successfully Treated Dupilumab-Resistant Patients With Rare Dominant Dystrophic Epidermolysis Bullosa With Atopic Dermatitis
Hai-Zhen Hui, Hong-Xing Guo, Bing-Jun Shi
American Journal of Therapeutics
|
June 15, 2026
Abrocitinib for Erythema Multiforme-like Drug Eruptions
Xiang-Yu Chen, Xin-Yu Wei, Bing-Jun Shi
American Journal of Therapeutics
|
November 4, 2025
JAK Inhibitors in the Treatment of Hailey-Hailey Disease: A Case Series and Mechanistic Exploration
Yu-Ting Gan, Yuan-Fang Wan, Bing-Jun Shi
American Journal of Therapeutics
|
February 27, 2026
Tofacitinib in Pigmented Purpuric Dermatoses
Yu-Ting Gan, Xing-Ying Liu, Hua Liu, et al.
American Journal of Therapeutics
|
March 2, 2026
Tislelizumab-Associated Toxic Epidermal Necrolysis
Zheng Guan, YuTing Gan, Qi Pan, et al.
Page
of 4